T. Rowe Price Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-92,248
| Closed | -$43K | – | 3108 |
|
2025
Q1 | $43K | Buy |
92,248
+14,746
| +19% | +$6.87K | ﹤0.01% | 2943 |
|
2024
Q4 | $57K | Sell |
77,502
-39,677
| -34% | -$29.2K | ﹤0.01% | 2909 |
|
2024
Q3 | $184K | Hold |
117,179
| – | – | ﹤0.01% | 2679 |
|
2024
Q2 | $197K | Buy |
117,179
+11,864
| +11% | +$19.9K | ﹤0.01% | 2595 |
|
2024
Q1 | $253K | Buy |
105,315
+4,624
| +5% | +$11.1K | ﹤0.01% | 2512 |
|
2023
Q4 | $155K | Hold |
100,691
| – | – | ﹤0.01% | 2614 |
|
2023
Q3 | $110K | Sell |
100,691
-7,695
| -7% | -$8.41K | ﹤0.01% | 2641 |
|
2023
Q2 | $249K | Sell |
108,386
-48,235
| -31% | -$111K | ﹤0.01% | 2443 |
|
2023
Q1 | $381K | Sell |
156,621
-37,492
| -19% | -$91.2K | ﹤0.01% | 2229 |
|
2022
Q4 | $371K | Buy |
194,113
+838
| +0.4% | +$1.6K | ﹤0.01% | 2282 |
|
2022
Q3 | $464K | Sell |
193,275
-4,166
| -2% | -$10K | ﹤0.01% | 2157 |
|
2022
Q2 | $367K | Buy |
197,441
+43,509
| +28% | +$80.9K | ﹤0.01% | 2348 |
|
2022
Q1 | $322K | Buy |
153,932
+10,300
| +7% | +$21.5K | ﹤0.01% | 2516 |
|
2021
Q4 | $566K | Buy |
143,632
+14,064
| +11% | +$55.4K | ﹤0.01% | 2327 |
|
2021
Q3 | $623K | Hold |
129,568
| – | – | ﹤0.01% | 2265 |
|
2021
Q2 | $595K | Buy |
129,568
+26,637
| +26% | +$122K | ﹤0.01% | 2299 |
|
2021
Q1 | $604K | Sell |
102,931
-77,144
| -43% | -$453K | ﹤0.01% | 2279 |
|
2020
Q4 | $616K | Sell |
180,075
-157,300
| -47% | -$538K | ﹤0.01% | 2158 |
|
2020
Q3 | $486K | Hold |
337,375
| – | – | ﹤0.01% | 2100 |
|
2020
Q2 | $673K | Buy |
337,375
+108,900
| +48% | +$217K | ﹤0.01% | 1942 |
|
2020
Q1 | $446K | Buy |
228,475
+35,100
| +18% | +$68.5K | ﹤0.01% | 2038 |
|
2019
Q4 | $803K | Buy |
193,375
+131,545
| +213% | +$546K | ﹤0.01% | 1975 |
|
2019
Q3 | $186K | Buy |
61,830
+188
| +0.3% | +$566 | ﹤0.01% | 2386 |
|
2019
Q2 | $388K | Buy |
61,642
+26,900
| +77% | +$169K | ﹤0.01% | 2209 |
|
2019
Q1 | $193K | Buy |
34,742
+800
| +2% | +$4.44K | ﹤0.01% | 2403 |
|
2018
Q4 | $225K | Buy |
33,942
+476
| +1% | +$3.16K | ﹤0.01% | 2368 |
|
2018
Q3 | $357K | Sell |
33,466
-141
| -0.4% | -$1.5K | ﹤0.01% | 2271 |
|
2018
Q2 | $403K | Buy |
33,607
+147
| +0.4% | +$1.76K | ﹤0.01% | 2230 |
|
2018
Q1 | $287K | Buy |
33,460
+284
| +0.9% | +$2.44K | ﹤0.01% | 2298 |
|
2017
Q4 | $328K | Sell |
33,176
-20,560
| -38% | -$203K | ﹤0.01% | 2233 |
|
2017
Q3 | $660K | Buy |
53,736
+20,600
| +62% | +$253K | ﹤0.01% | 1960 |
|
2017
Q2 | $545K | Hold |
33,136
| – | – | ﹤0.01% | 2031 |
|
2017
Q1 | $475K | Buy |
33,136
+17
| +0.1% | +$244 | ﹤0.01% | 2083 |
|
2016
Q4 | $458K | Hold |
33,119
| – | – | ﹤0.01% | 2082 |
|
2016
Q3 | $598K | Sell |
33,119
-17,600
| -35% | -$318K | ﹤0.01% | 1938 |
|
2016
Q2 | $728K | Buy |
50,719
+1,620
| +3% | +$23.3K | ﹤0.01% | 1814 |
|
2016
Q1 | $587K | Buy |
49,099
+25,100
| +105% | +$300K | ﹤0.01% | 1901 |
|
2015
Q4 | $319K | Sell |
23,999
-5,700
| -19% | -$75.8K | ﹤0.01% | 2131 |
|
2015
Q3 | $319K | Buy |
29,699
+5,900
| +25% | +$63.4K | ﹤0.01% | 2121 |
|
2015
Q2 | $192K | Sell |
23,799
-62,001
| -72% | -$500K | ﹤0.01% | 2357 |
|
2015
Q1 | $81K | Sell |
85,800
-5,987,790
| -99% | -$5.65M | ﹤0.01% | 2485 |
|
2014
Q4 | $5.53M | Sell |
6,073,590
-73,000
| -1% | -$66.4K | ﹤0.01% | 1444 |
|
2014
Q3 | $8.67M | Buy |
6,146,590
+22,500
| +0.4% | +$31.7K | ﹤0.01% | 1340 |
|
2014
Q2 | $9.86M | Sell |
6,124,090
-330,600
| -5% | -$532K | ﹤0.01% | 1322 |
|
2014
Q1 | $11.2M | Sell |
6,454,690
-27,600
| -0.4% | -$47.8K | ﹤0.01% | 1272 |
|
2013
Q4 | $11.7M | Sell |
6,482,290
-7,349,756
| -53% | -$13.2M | ﹤0.01% | 1247 |
|
2013
Q3 | $32.8M | Sell |
13,832,046
-588,280
| -4% | -$1.39M | 0.01% | 953 |
|
2013
Q2 | $31.3M | Buy |
+14,420,326
| New | +$31.3M | 0.01% | 939 |
|